Skip to main content

Boston Failed To Escape An IVC Filter Lawsuit

Boston Failed To Escape An IVC Filter Lawsuit

Boston Failed To Escape An IVC Filter Lawsuit

Introduction

In an order submitted on November 27, Judge Richard Mills of the U.S. District Court for the Central District of Illinois denied Boston Scientific Corporation’s motion to dismiss a lawsuit involving complaints against its Greenfield IVC filter. The Illinois judge ruled that the plaintiff asserted plausible claims regarding design defect and inadequate warnings about the IVC filter's hazards.

As per the court order, Boston must face the lawsuit for negligent conduct, extensively marketing the device as safe to use, and failure to warn doctors about associated permanent risks of the blood-clot trapping filter.

In 2005, Boston Scientific recalled about 18,000 Greenfield filters following reports that the filter parts are prone to detach and cause heart or lung embolism. A 2016 publication regarding IVC filter complications stated perforation, migration, and fractures as possible adverse effects. About 9,000 lawsuits are filed against Cook Medical and C.R. Bard over complaints regarding their blood clot filter complications. There is no multidistrict litigation (MDL) formed for Greenfield filter lawsuits, but lawyers have filed individual cases across the nation.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Attorneys Seek Reconsideration of Talc MDL Daubert Ruling

Categories: General

Plaintiffs’ attorneys are urging the U.S. District Judge overseeing the talcum powder lawsuit MDL to reconsider a recent decision for a second round…

Philips resolves DreamStation suits for $1.1B

Categories: Settlements

Dutch medical technology company Philips has finalized a $1.1 billion settlement in the United States to address lawsuits concerning faulty…

FDA OKs Generic OTC Naloxone Spray Approved by FDA

Categories: FDA Related

The FDA has granted approval for Amneal Pharmaceuticals to release a generic 4 mg naloxone hydrochloride nasal spray for over-the-counter (OTC) use, an announcement made in a press release.

Our Legal Drafting Services    
start @ $25 per hour.